December 27, 2024 8:07am

Waiting for year’s end, “a desire for a fresh start, a change in circumstances or because the current year has been challenging and you want it to be over”

Pre-open Indications: go with the flow

Never leave an investor uninform

Remember that overnight and pre-open actions’ futures and markets doesn’t necessarily translate into actual trading in today’s market session.

My interpretation of the morning’s numbers is written to be informative; it’s built on what happened or will happen behind the headline today!

 

Thursday’s night’s update … RegMed Investors (RMi) Closing Bell: sector ascended after being under pressure … https://www.regmedinvestors.com/articles/13745

 

Friday: The pre-open Dow futures are DOWN -0.30% or (-133 points), the S&P futures are DOWN -0.32% or (-19 points) and the Nasdaq futures are DOWN -0.31% or (-67 points)

  • Stock futures declined Friday, 12/27/24,
  • European stocks were higher,
  • Asia-Pacific markets trade mixed.

 

Henry’omics: We need to more than consider the economic environment to comprehend the micro re “our” universe of cell and gene therapy companies

Thursday: The Dow closed UP +28.77 points or +0.07%, the S&P closed DOWN -2.45 points or -0.04% while the Nasdaq closed DOWN -10.77 points or -0.05%

Thursday’s advance/decline line ended with a positive close at the close of 28 incliner, 6 decliners and 1 flat

The 3 major U.S. indexes are in the green week to date after posting strong back-to-back gains at the start of the shortened holiday week. The S&P 500 is up 1.8% so far this week. The broad market index posted its best Christmas Eve performance since 1974, the Dow has gained 1.1% and the Nasdaq 2.3% is higher.

Economic Data Docket: multiple … Chicago PMI, ISM Manufacturing PMI, ISM Manufacturing New Orders, ISM Manufacturing Prices Paid, ISM Manufacturing Employment and Construction Spending

 

Q4/24: December = 1 holiday, 12 negative and 5 positive closes

  • November 10 negative and 9 positive closes
  • October: 8 positive and 15 negative closes

 

Companies in my headlights – It’s your decision; I provide ideas and context 

I post about “indication intelligence” looking toward investment conferences … to assist investors with insight into sector vulnerabilities and strengths. A dictionary definition of “indicate” refers to something less than a certainty; an indication could be a signal of being oversold or overbought, a recommendation, or grounds for inferring or a basis for believing.

  • Let 'em roll!

The BOTTOM LINE:  There are clear winners with mostly losers in December …

  • Think about it; the biggest problem the cell and gene therapy sector has …  99% of them have no earnings! If rates are higher for longer, that means that sector companies will continue to struggle or be unable to raise capital and therefore be subject to debt servicing firms!

I seem to be asking a question followed by a question …

  • Do we need to brace ourself for more economics and their down trending affect?
  • Is this market STILL “bubblicious” my concerns are macroeconomic and valuation

Welcome to my world of defining the “grey’ in our universe!

  • The sector is what it is, until it isn’t and even then, it doesn’t seem to be… as NOT much changes as the sector’s share pricing rides the waves of volatility, algorithms, electronic trading and short covering.
  • I am more frequently right than consequentially wrong; if I wanted to be liked, I wouldn’t have been an analyst/journalist.

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice. All investments are subject to risks. Investors should consider investment objectives.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.  Regulation Analyst Certification (Reg AC): The research analyst primarily responsible for the content of this report certifies the following under Reg AC: I hereby certify that all views expressed in this report accurately reflect my personal views about the subject company or companies and it’s or their securities. I also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report.

Henry McCusker, the editor and publisher of RegMed Investors could hold or have positions securities referred to in this publication and he will NOTIFY investors of holdings.